Dezima Pharma In-Licenses CETP Inhibitor Program From Mitsubishi Tanabe Pharma Corporation
1/22/2013 9:38:37 AM
More...
|
AnGes MG Inc. Enters Into the Definitive Agreement With Mitsubishi Tanabe Pharma Corporation for Exclusive Marketing Rights of Collategene® in the United States
10/24/2012 8:44:31 AM
More...
|
Covagen Inks $146 Million Pact With Mitsubishi Tanabe Pharma Corporation
10/17/2012 7:20:48 AM
More...
|
Aris Global, LLC's New Generation Pharmacovigilance and Clinical Safety Solution Goes Live at Mitsubishi Tanabe Pharma Corporation
7/26/2012 10:00:01 AM
More...
|
Aris Global, LLC's New Generation Pharmacovigilance and Clinical Safety Solution Goes Live at Mitsubishi Tanabe Pharma Corporation
7/26/2012 9:08:34 AM
More...
|
OncoEthix In-Licenses OTX015, an Anticancer Bromodomain Inhibitor From Mitsubishi Tanabe Pharma Corporation
6/15/2012 9:11:03 AM
More...
|
Synageva BioPharma (GEVA) and Mitsubishi Tanabe Pharma Corporation Expand Development Collaboration With Second Program
4/2/2012 10:41:12 AM
More...
|
Strategic Alliance Between Medicago, Inc. and Mitsubishi Tanabe Pharma Corporation Highlighted by Canadian Government in Japan
3/27/2012 10:49:47 AM
More...
|
Medicago, Inc., Mitsubishi Tanabe Pharma Corporation Strikes $33 Million Pact to Develop New Vaccines
3/6/2012 6:57:34 AM
More...
|
Nuron Biotech Licenses HibTITER® Vaccine to Mitsubishi Tanabe Pharma Corporation for Japanese Market
1/13/2012 6:30:43 AM
More...
|
|